#Intuitive Surgical

2개의 글

11 de mayo de 2026

ISRG Intuitive Surgical perspectiva 2026: el monopolio de la cirugía robótica y el ciclo da Vinci 5

Análisis completo de Intuitive Surgical (NASDAQ: ISRG) para 2026: modelo razor-and-blade del sistema da Vinci, FDA clearance del da Vinci 5, Ion para biopsia pulmonar, competencia de Medtronic Hugo, y cómo valorar una acción de crecimiento sin dividendo desde España y Latinoamérica.

ISRG Intuitive Surgical da Vinci

May 11, 2026

ISRG Intuitive Surgical Stock Outlook 2026: The da Vinci 5 Upgrade Cycle and Robotic Surgery's Next Decade

Intuitive Surgical stock analysis for 2026: da Vinci 5 FDA clearance and upgrade cycle implications, razor-and-blade model economics, Ion lung biopsy platform growth, competitive threats from Medtronic Hugo and J&J Ottava, and valuation framework for growth investors.

ISRG Intuitive Surgical da Vinci